Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.73 CAD | +1.36% | +1.22% | -30.54% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.54% | 95.26M | |
+48.80% | 56.95B | |
+39.98% | 40.26B | |
-7.08% | 39.32B | |
-4.42% | 28.37B | |
+12.29% | 26.45B | |
-17.91% | 19.41B | |
+29.22% | 12.54B | |
+25.74% | 12.21B | |
-0.22% | 12.15B |
- Stock Market
- Equities
- EPRX Stock
- News Eupraxia Pharmaceuticals Inc.
- Eupraxia Pharmaceuticals Inc. Brief: Says incurred a net loss of US$10.6 million for Q4, versus $7.8 million for the three months ended December 31, 2022